http://www.oncolink.org/whatsnew/ OncoLink - What's New this Week Wed, 19 Jun 2013 01:34:26 GMT http://www.oncolink.org/conferences/conferences1.cfm?c=433 Reporting from the Particle Therapy Co-Operative Group, PTCOG in Essen, Germany, June 2 - 8, 2013. An organization for those interested in proton, light ion and heavy charged particle radiotherapy. Mon, 10 Jun 2013 04:00:00 GMT http://www.oncolink.org/conferences/conferences1.cfm?c=428 OncoLink reporters provide in-depth coverage of scientific presentations from the Annual American Society of Clinical Oncology (ASCO) Meeting in Chicago, Illinois. Mon, 03 Jun 2013 04:00:00 GMT http://www.oncolink.org/resources/article.cfm?c=450&id=1101 This continuing education activity is designed for nurses and nurse practitioners in clinical practice to learn about chemotherapy and biotherapeutic agents approved by the US FDA in 2012. Thu, 06 Jun 2013 04:00:00 GMT http://www.oncolink.org/enews/june-2013.html Check out our June eNewsletter and subscribe to receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email. Thu, 06 Jun 2013 04:00:00 GMT http://www.oncolink.orghttp://www.oncolink.org/blogs/index.php/2013/05/cancer-survivorship-navigating-life-after-cancer/ This webinar provides information, tips and resources on transitioning from patient to survivor and making the most of life after cancer. Thu, 30 May 2013 04:00:00 GMT http://www.oncolink.org/types/article.cfm?c=68&id=9666 Exercise is one of the best ways to maintain strength, energy, mobility and cope with cancer related fatigue during and after cancer treatment. Fri, 24 May 2013 04:00:00 GMT http://www.oncolink.org/types/article.cfm?c=559&id=9669 Exercises to aid in recovery from Keystone Flap Surgery. Fri, 24 May 2013 04:00:00 GMT http://www.oncolink.org/treatment/article.cfm?c=209&id=581 A PET/CT scan is an imaging exam performed to localize metabolic activity inside the body, which helps in detecting cancer and distinguishing between benign and cancerous tissues. Tue, 21 May 2013 04:00:00 GMT http://www.oncolink.org/types/article1.cfm?id=9656 BRCA1 & 2 are short for breast cancer susceptibility gene 1 & 2, which are present in everyone. Women with abnormal BRCA 1 & 2 are at increased risk of developing certain cancers. Learn more. Tue, 14 May 2013 04:00:00 GMT http://www.oncolink.org/blogs/index.php/2013/04/answers-to-your-nutrition-and-diet-questions/ Are you confused by all the information on cancer and nutrition; what to eat and what to avoid? The program reviews the current nutritional information and guidelines for cancer patients and survivors. Did you miss our webinar? Listen and watch the archive. Wed, 08 May 2013 04:00:00 GMT http://www.oncolink.org/blogs/index.php/2013/04/after-breast-cancer-survivor-education-webchat/ Watch and listen to the archive of this webinar with Dr. Schmitz, Principal Investigator on the groundbreaking PAL trial, which demonstrated that exercise and weight training, is safe for breast cancer survivors, and decreased the risk of developing lymphedema. Addresses issues that commonly affect breast cancer survivors and explore ways to manage these concerns. Fri, 03 May 2013 04:00:00 GMT http://www.oncolink.org/resources/article1.cfm?id=1100 New Oncology Medical Minute. Non-Hodgkin's lymphoma (NHL) is the most common hematologic malignancy in adults, and the sixth most common cancer diagnosed in the United States each year. Fri, 03 May 2013 04:00:00 GMT http://www.oncolink.org/treatment/article.cfm?c=154&id=579 Stereotactic radiation, often referred to as stereotactic body radiation therapy (SBRT), stereotactic ablative radiotherapy (SABR) or stereotactic radiosurgery (SRS), is a form of radiation therapy that very precisely delivers a high dose of radiation to a tumor. Tue, 30 Apr 2013 04:00:00 GMT http://www.oncolink.org/resources/article.cfm?c=412&id=1097 This continuing education activity is designed for nurses and nurse practitioners in clinical practice to learn about the assessment, prevention and control of chemotherapy-induced nausea and vomiting (CINV). This activity has been approved for 1.0 contact hour. Mon, 22 Apr 2013 04:00:00 GMT